Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARADIGM4TB (UNITE4TB-01)
PACTR202403493915530Phase 2Not yet recruiting
- Sponsor
- University College London
- Start
- Apr 2024
- Countries
- 10
01
Overview
Phase 2, randomised trial in Tuberculosis (TB) and pulmonary tuberculosis (TB) (12 arms), sponsored by University College London. Primary endpoints: Phase 2B bacteriologic response and Phase 2C clinical outcome. Planned start Apr 2024; status: not yet recruiting.
02
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202403493915530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202403493915530.